Tachycardia increases NADPH oxidase activity and RyR2 S-glutathionylation in ventricular muscle

被引:100
作者
Sánchez, G
Pedrozo, Z
Domenech, RJ
Hidalgo, C
Donoso, P
机构
[1] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 7, Chile
[2] Univ Chile, Fac Med, Ctr FONDAP Estudios Mol Celula, Santiago 7, Chile
关键词
calcium release channels; ryanodine receptor; redox modulation; NOX activity; reactive oxygen species; cardiac muscle;
D O I
10.1016/j.yjmcc.2005.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have shown previously that electrically induced tachycardia effectively produces myocardial preconditioning. Among other effects, tachycardia increases calcium release rates in microsomal fractions enriched in sarcoplasmic reticulum (SR) isolated from dog cardiac ventricular muscle. Here, we report that preconditioning tachycardia increased twofold the NADPH oxidase activity of isolated SR-enriched microsomal fractions, measured as NADPH-dependent generation of superoxide anion and hydrogen peroxide. Tachycardia also augmented the association of rac1 and the NADPH oxidase cytosolic subunit p47(phox) to the microsomal fraction, without modifying the content of the membrane integral subunit gp91(phox). Microsomes from control animals displayed endogenous S-glutathionylation of cardiac ryanodine receptors (RyR2); in microsomal fractions isolated after tachycardia RyR2 S-glutathionylation levels were 1.7-fold higher than in controls. Parallel in vitro experiments showed that NADPH produced a transient increase in calcium release rates and enhanced 1.6-fold RyR2 S-glutathionylation in control microsomes but had marginal or no effects on microsomes isolated after tachycardia. Catalase plus superoxide dismutase, and the NADPH oxidase inhibitors apocynin and diphenyleneiodonium prevented the in vitro stimulation of calcium release rates and RyR2 S-glutathionylation induced by NADPH, suggesting NADPH oxidase involvement. Conversely, addition of reducing agents to vesicles incubated with NADPH markedly inhibited calcium release and prevented RyR2 S-glutathionylation. We propose that tachycardia stimulates NADPH oxidase activity, which by enhancing RyR2 redox modifications such as S-glutathionylation, would contribute to sustain faster calcium release rates during conditions of increased cardiac activity. This response may be an important component of tachycardia-induced preconditioning. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:982 / 991
页数:10
相关论文
共 40 条
[1]   Effects of S-glutathionylation and S-nitrosylation on calmodulin binding to triads and FKBP12 binding to type 1 calcium release channels [J].
Aracena, P ;
Tang, WT ;
Hamilton, SL ;
Hidalgo, C .
ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (7-8) :870-881
[2]   S-glutathionylation decreases Mg2+ inhibition and S-nitrosylation enhances Ca2+ activation of RyR1 channels [J].
Aracena, P ;
Sánchez, G ;
Donoso, P ;
Hamilton, SL ;
Hidalgo, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (44) :42927-42935
[3]   New concepts in reactive oxygen species and cardiovascular reperfusion physiology [J].
Becker, LB .
CARDIOVASCULAR RESEARCH, 2004, 61 (03) :461-470
[4]  
Bell RM, 2003, CIRCULATION, V108, P46
[5]   Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice [J].
Bendall, JK ;
Cave, AC ;
Heymes, C ;
Gall, N ;
Shah, AM .
CIRCULATION, 2002, 105 (03) :293-296
[6]   Calcium signalling: Dynamics, homeostasis and remodelling [J].
Berridge, MJ ;
Bootman, MD ;
Roderick, HL .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (07) :517-529
[7]   Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis [J].
Brennan, JP ;
Wait, R ;
Begum, S ;
Bell, JR ;
Dunn, MJ ;
Eaton, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41352-41360
[8]   Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II - Induced cardiac hypertrophy [J].
Byrne, JA ;
Grieve, DJ ;
Bendall, JK ;
Li, JM ;
Gove, C ;
Lambeth, JD ;
Cave, AC ;
Shah, AM .
CIRCULATION RESEARCH, 2003, 93 (09) :802-804
[9]   The vascular NAD(P)H oxidases as therapeutic targets cardiovascular diseases [J].
Cai, H ;
Griendling, KK ;
Harrison, DG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) :471-478
[10]   A REDOX-BASED MECHANISM FOR CARDIOPROTECTION INDUCED BY ISCHEMIC PRECONDITIONING IN PERFUSED RAT-HEART [J].
CHEN, W ;
GABEL, S ;
STEENBERGEN, C ;
MURPHY, E .
CIRCULATION RESEARCH, 1995, 77 (02) :424-429